Prime Medicine, once-buzzy biotech, announces layoffs, new CEO
Prime Medicine, a biotech whose wild ambitions for a powerful gene editing technology sank as the biotech market slumped, announced Monday ...
Prime Medicine, a biotech whose wild ambitions for a powerful gene editing technology sank as the biotech market slumped, announced Monday ...
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you ...
Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the ...
Robert F. Kennedy Jr. forcing Peter Marks out of the Food and Drug Administration has blown a hole in the ...
MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to ...
Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is ...
Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the ...
Ascentage Pharma, a China-based drug developer with global ambitions, now has $126.4 million from a U.S. IPO that will mainly ...
Robert F. Kennedy Jr.’s disclosure on Wednesday that he invested in a gene-editing biotech belies a years-long track record of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.